In this week's podcast we chat with David Brown, co-founder at Stratcann, about:

• Opposition to Canadian legalisation
• Challenges for domestic suppliers in Canada
• How cannabis is taxed in Canada
• Law enforcement approaches to cannabis in Canada
• Lessons for the legalise cannabis cause in Australia Stratcann

AltMed
https://altmed.com.au/

Stratcann
https://stratcann.com/

Support the show

Join Andrew Dowling and Mitch Kurtz as they dive into the fascinating world of mushrooms and natural tonics with special guest Mason Taylor, founder of SuperFeast. In this episode, we journey through the transformative potential of these ancient remedies and their role in modern wellness.

Discover the secrets behind:

The benefits of medicinal mushrooms
Natural tonic herbs for vitality
Tips for integrating these remedies into your daily life

Get ready for an eye-opening conversation packed with insights into holistic health and the power of nature's pharmacy. Don't forget to like, subscribe, and hit the bell for more episodes of AltMed.

#AltMed #Mushrooms #NaturalHealth #Wellness #SuperFeast

SuperFeast
https://www.superfeast.com.au/

AltMed
https://altmed.com.au/

Support the show

In this week's podcast we chat with Abe Gray, Founder of Whakamana Cannabis Museum about Cannabis Politics in NZ.

Whakamana Cannabis Museum
https://cannabis.kiwi.nz/

 AltMed
https://altmed.com.au/

Support the show

In this week's podcast we chat with Sean Maloney, Legal Counsel and Commercial Manager of MediCann Health, about: 

• ASX continuous disclosure obligations
• Use of ASX announcements to advertise medicinal cannabis products and also bury bad news
• Current state of advertising enforcement against medicinal cannabis companies.

MediCann Health:
https://www.medicannhealth.com.au/

AltMed:
https://altmed.com.au

Support the show

In this week's podcast we chat with Michael Sassano, CEO and Founder at Somai Pharmaceuticals about:

• Cannabis across the globe
• Cannabis Mergers and Acquisitions
• EU-GMP and vertical integration
• Cannabis extracts
• Pharmaceutical cannabis products

Somai Pharmaceuticals: https://somaipharma.eu/

AltMed: https://altmed.com.au/

Support the show

In this week's podcast we chat with Panapa Ehau and Porou Tawhiwhirangi, Founder and Head Grower at Rua Bioscience about:

• Medical cannabis in New Zealand
• NZ cannabis genetics
• Demographics and cannabis
• NZ cannabis history

Rua Bioscience:
https://www.ruabio.com/

AltMed:
https://altmed.com.au/

Support the show

In this week's podcast we chat with Lisa Varley, CEO of The Entourage Effect, about:

• Cannabis registration
• Distribution vs product strategy
• Cannabis company success and pitfalls
• Cannabis market crowding

The Entourage Effect
https://theentourageeffect.com.au/

AltMed
https://altmed.com.au/

Support the show

In this week's podcast we chat with Craig Frawley, Compounding Pharmacist at My Compounder, about:

• Compounding Cannabis
• Early days of cannabis dispensing
• The Pharmacy legislation
• Cannabis compounds and emerging science
• Veterinary cannabis products
• The first MDMA script in Australia

My Compounder
https://mycompounder.com.au/

AltMed
https://altmed.com.au/

Support the show

In this week's podcast we chat with Dr Zaina Cheema about:

• How doctors should be dosing medical cannabis
• Challenges doctors face when dealing with the Department of Veteran Affairs for veteran patients
• Tips for staying mentally healthy (spoiler: eat well and sleep well!)
• Preventative medicine and current trends in medicine regarding
• Blending of medical cannabis treatments, particularly for treating smoking cessation and insomnia
• Pathophysiology of disease

Dr Zaina Cheema
https://au.linkedin.com/in/zainacheema

AltMed
https://altmed.com.au/

Support the show

In this week's podcast we chat with Dr Bryce Joynson about:

• The ADHD brain and how it functions.
• Responsible prescribing of medical cannabis.
• The proliferation of ADHD specialist telehealth clinics.
• Prevalence and causes of common medical conditions in Australia including obesity and anxiety.
• Medical ethics and doctors’ obligations in relation to disclosing conflicts of interest to patients.

Support the show